Free Trial

STERIS (STE) Competitors

STERIS logo
$223.14 -1.61 (-0.71%)
As of 01:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, BAX, HOLX, GMED, and MASI

Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry.

STERIS vs.

STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings.

94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Becton, Dickinson and Company had 13 more articles in the media than STERIS. MarketBeat recorded 31 mentions for Becton, Dickinson and Company and 18 mentions for STERIS. STERIS's average media sentiment score of 1.32 beat Becton, Dickinson and Company's score of 1.27 indicating that STERIS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STERIS
14 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
24 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 1.0%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.0%. STERIS pays out 48.4% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has raised its dividend for 20 consecutive years and Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STERIS$5.40B4.09$378.24M$4.7147.70
Becton, Dickinson and Company$20.64B2.88$1.71B$6.0234.37

STERIS has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500.

STERIS presently has a consensus price target of $258.75, indicating a potential upside of 15.18%. Becton, Dickinson and Company has a consensus price target of $272.86, indicating a potential upside of 31.89%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than STERIS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STERIS
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Becton, Dickinson and Company
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

STERIS has a net margin of 8.66% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat STERIS's return on equity.

Company Net Margins Return on Equity Return on Assets
STERIS8.66% 13.91% 8.64%
Becton, Dickinson and Company 8.47%15.74%7.29%

Becton, Dickinson and Company received 265 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.46% of users gave Becton, Dickinson and Company an outperform vote while only 59.16% of users gave STERIS an outperform vote.

CompanyUnderperformOutperform
STERISOutperform Votes
339
59.16%
Underperform Votes
234
40.84%
Becton, Dickinson and CompanyOutperform Votes
604
62.46%
Underperform Votes
363
37.54%

Summary

Becton, Dickinson and Company beats STERIS on 12 of the 21 factors compared between the two stocks.

Get STERIS News Delivered to You Automatically

Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STE vs. The Competition

MetricSTERISSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$22.01B$9.15B$5.56B$18.96B
Dividend Yield1.01%1.64%5.11%4.03%
P/E Ratio47.7019.2722.4432.71
Price / Sales4.0971.13393.9527.84
Price / Cash15.7319.6738.1817.53
Price / Book3.434.956.774.47
Net Income$378.24M$284.66M$3.22B$1.02B
7 Day Performance-0.81%0.01%1.45%0.50%
1 Month Performance-0.37%1.87%3.96%-2.83%
1 Year Performance9.56%-17.14%16.07%4.36%

STERIS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STE
STERIS
4.5006 of 5 stars
$223.14
-0.7%
$258.75
+16.0%
+9.8%$21.92B$5.40B47.3816,000Upcoming Earnings
Short Interest ↑
Positive News
BDX
Becton, Dickinson and Company
4.9057 of 5 stars
$205.10
+0.0%
$272.86
+33.0%
-11.8%$58.89B$20.64B34.0777,000Earnings Report
Dividend Announcement
Positive News
Gap Down
EW
Edwards Lifesciences
4.6048 of 5 stars
$75.55
-0.6%
$79.45
+5.2%
-10.8%$44.41B$5.25B10.8417,300Short Interest ↓
Analyst Revision
Positive News
IDXX
IDEXX Laboratories
3.9573 of 5 stars
$433.99
-0.8%
$523.75
+20.7%
-12.2%$35.17B$3.90B40.6710,800Earnings Report
Positive News
Gap Up
RMD
ResMed
4.0268 of 5 stars
$234.06
-0.8%
$258.83
+10.6%
+10.5%$34.38B$5.02B27.638,160Dividend Announcement
DXCM
DexCom
4.9426 of 5 stars
$71.18
-0.7%
$99.00
+39.1%
-44.0%$27.91B$4.03B49.787,600Positive News
PODD
Insulet
4.481 of 5 stars
$259.52
-0.5%
$292.06
+12.5%
+46.7%$18.23B$2.07B44.822,600Upcoming Earnings
Analyst Forecast
News Coverage
Positive News
BAX
Baxter International
4.3661 of 5 stars
$30.60
+1.3%
$38.56
+26.0%
-22.7%$15.70B$10.64B-23.9160,000Earnings Report
News Coverage
Gap Up
HOLX
Hologic
4.8718 of 5 stars
$58.08
+0.1%
$84.62
+45.7%
-23.2%$13.03B$4.04B18.326,940Positive News
GMED
Globus Medical
4.8073 of 5 stars
$72.58
-0.3%
$96.91
+33.5%
+44.2%$9.98B$2.52B96.772,600Upcoming Earnings
Short Interest ↑
MASI
Masimo
3.8021 of 5 stars
$164.04
+0.2%
$194.80
+18.8%
+19.8%$8.86B$2.09B113.136,200Upcoming Earnings
Positive News

Related Companies and Tools


This page (NYSE:STE) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners